As part of WuXi AppTec's ongoing efforts to collaboratively foster new thinking and actionable approaches in advancing breakthroughs for patients, we are pleased to share with you our new "BOLD" series – "Breaking Barriers, Opening New Horizons, Leading Next Generation Therapeutics, and Delivering on the Promise for Patients." – where we highlight bold think, bold action, and notable advances in tackling global health challenges to build an impactful future.
wxpress-wuxi-apptec
As part of WuXi AppTec's ongoing efforts to collaboratively foster new thinking and actionable approaches in advancing breakthroughs for patients, we are pleased to share with you our new "BOLD" series – "Breaking Barriers, Opening New Horizons, Leading Next Generation Therapeutics, and Delivering on the Promise for Patients." – where we highlight bold think, bold action, and notable advances in tackling global health challenges to build an impactful future.

Events

LOAD MORE

Insights

Fresh Perspectives

We spotlight on cancer in this edition, and highlight fresh perspectives from several emerging companies on their bold approaches and progresses across a spectrum of modalities including next generation small molecule, radiopharmaceuticals, and cellular medicine.
  • emanuele-ostuni
    Emanuele Ostuni
    VIDEO
    CEO
    ARTBIO
  • shengfang-jin
    Shengfang Jin
    VIDEO
    President & CEO
    Ensem Therapeutics
  • peretz-partensky
    Peretz Partensky
    VIDEO
    Co-Founder & CEO
    ImmuneBridge
  • manfred-r-diger
    Manfred Rüdiger
    VIDEO
    CEO
    Ariceum Therapeutics

R&D Productivity

Efficient and productive R&D is essential for the success in delivering new therapies and healthcare solutions to transform patient outcomes. What are the main challenges in biopharma R&D productivity? What emerging technologies can enhance biopharma R&D productivity and how will they impact patient care? Can data analytics and machine learning streamline drug development, reduce costs, and improve therapy success rates?
  • jon-moore
    Jon Moore
    VIDEO
    Co-Founder & CEO
    Epitopea
  • taku-nakahara
    Taku Nakahara
    VIDEO
    Founder & CEO
    Metagen Therapeutics
  • giuseppe-mazza
    Giuseppe Mazza
    VIDEO
    CEO & Co-Founder
    Engitix; Honorary Associate Professor, UCL
  • ishita-shah
    Ishita Shah
    VIDEO
    CEO & Co-Founder
    Matrubials
  • lars-nieba
    Lars Nieba
    VIDEO
    CEO
    Engimmune Therapeutics
  • avencia-s-nchez-mej-as
    Avencia Sánchez-Mejías
    VIDEO
    Co-Founder & CEO
    Integra Therapeutics
  • leslie-williams
    Leslie Williams
    VIDEO
    Co-Founder, President & CEO
    hC Bioscience
  • jim-broderick
    Jim Broderick
    VIDEO
    CEO & Founder
    Palleon Pharmaceuticals
LOAD MORE

Accelerate Science Translation

Given the science advances in the past decade, does the translation from bench science into bedside accelerate, and bring breakthrough therapies to the patients faster? What are the top challenges and what steps should the industry take to enhance the success rate from science to therapies?
  • philip-kantoff
    Philip Kantoff
    VIDEO
    Co-Founder & CEO
    Convergent Therapeutics
  • roy-maute
    Roy Maute
    VIDEO
    Co-Founder & CSO
    Pheast Therapeutics
  • danuta-jeziorska
    Danuta Jeziorska
    VIDEO
    CEO & Co-Founder
    Nucleome Therapeutics
  • tianjing-tj-deng
    Tianjing (TJ) Deng
    VIDEO
    CEO & Co-Founder
    Pyrotech Therapeutics
  • paul-lammers
    Paul Lammers
    VIDEO
    CEO
    Triumvira Immunologics
  • dina-burkitbayeva
    Dina Burkitbayeva
    VIDEO
    CEO & Co-Founder
    Freedom Biosciences
  • robert-li
    Robert Li
    VIDEO
    Founder & CEO
    LTZ Therapeutics
  • catherine-sabatos-peyton
    Catherine Sabatos-Peyton
    VIDEO
    CEO
    Larkspur Biosciences
LOAD MORE

Future Outlook

New technologies and scientific breakthroughs are rapidly changing the landscape of drug R&D. Which areas of drug R&D are most promising for breakthroughs in the coming years, and why? How will this continue to evolve? How will the regulatory landscape evolve in the future, and what impact will this have on drug R&D?
  • nerissa-kreher
    Nerissa Kreher
    VIDEO
    CMO
    Entrada Therapeutics
  • brian-mcveigh
    Brian McVeigh
    VIDEO
    Chairman, CEO & Co-Founder
    Code Biotherapeutics
  • laksh-aithani
    Laksh Aithani
    VIDEO
    CEO & Co-Founder
    CHARM Therapeutics
  • ping-cao
    Ping Cao
    VIDEO
    Co-Founder & CEO
    BridGene Biosciences
  • eddine-saiah
    Eddine Saiah
    VIDEO
    CSO
    Stablix
  • dennis-zaller
    Dennis Zaller
    VIDEO
    CSO
    ROME Therapeutics
  • jeff-bluestone
    Jeff Bluestone
    VIDEO
    CEO & Co-Founder
    Sonoma Biotherapeutics; Professor Emeritus, UCSF Diabetes Center
  • theresa-heah
    Theresa Heah
    VIDEO
    CEO
    Intergalactic Therapeutics
LOAD MORE

The Future of Small Molecules

Small molecules are keep evolving. What would be the future of small molecule drugs? What challenges and opportunities lie ahead? And most importantly, how can we fully unlock the potential of small molecules?
  • uttam-surana
    Uttam Surana
    VIDEO
    Adjunct Professor
    Department of Pharmacology, National University of Singapore; Co-Founder, Aldropika Therapeutics
  • jake-becraft
    Jake Becraft
    VIDEO
    CEO & Co-Founder
    Strand Therapeutics
  • neil-dhawan
    Neil Dhawan
    VIDEO
    CEO & Co-Founder
    Totus Medicines
  • brian-gladsden
    Brian Gladsden
    VIDEO
    CEO
    Mosaic Therapeutics
  • roberto-iacone
    Roberto Iacone
    VIDEO
    CEO
    Alentis Therapeutics
  • lori-lyons-williams
    Lori Lyons-Williams
    VIDEO
    President & CEO
    Abdera Therapeutics
  • richard-markus
    Richard Markus
    VIDEO
    President & CEO
    Dantari
  • szabolcs-nagy
    Szabolcs Nagy
    VIDEO
    Co-Founder & CEO
    Turbine
LOAD MORE

R&D Cost Transformation

The increasing costs are notably accentuated when considering the complexities of innovative therapy development. Where can we find opportunities to bend the cost curves downward, ultimately benefiting patients and healthcare systems on a larger scale?
  • nicholas-siciliano
    Nicholas Siciliano
    VIDEO
    CEO & Co-Founder
    Vittoria Biotherapeutics
  • vishal-doshi
    Vishal Doshi
    VIDEO
    Chairman & CEO
    AUM Biosciences
© 2026 WuXi AppTec. All Rights Reserved.Privacy Policy